TMCnet News
Research and Markets: Corneal Neovascularization - Pipeline Review, H1 2014DUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/sz87mj/corneal) has announced the addition of the "Corneal Neovascularization - Pipeline Review, H1 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Corneal Neovascularization, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Corneal Neovascularization and special features on late-stage and discontinued projects. Drug profiles/recods featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Scope
Companies Mentioned:
For more information visit http://www.researchandmarkets.com/research/sz87mj/corneal
|